Successful immune checkpoint inhibitor rechallenge after immune-related pericarditis: Clinical case series

Pericardial diseases secondary to immune checkpoint inhibitors (ICI) are rare. Here, we describe two cases of immune-related pericarditis caused by ICI for treatment of advanced NSCLC. Select patients can be successfully rechallenged with ICI after immune-related pericardial disease.

Detalhes bibliográficos

Principais autores:	Adrian M. Chye, Ina I. C. Nordman, Aaron L. Sverdlov
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2022-08-01
coleção:	Frontiers in Cardiovascular Medicine
Assuntos:	immune checkpoint inhibitors immune-related adverse events cardiotoxicity pericarditis lung cancer
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fcvm.2022.964324/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!